ORGO FY 2017 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$5M

Operating Income

-$5M

Net Income

-$2M

EPS (Diluted)

$-0.03

Cash Flow

Operating Cash Flow

-$586,604

Free Cash Flow

-$3M

Stock-Based Comp.

$919,000

Balance Sheet

Total Assets

$313M

Total Liabilities

$15M

Stockholders' Equity

$298M

Cash & Equivalents

$125,886

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$5M	-$208,698	-2100.2%
Operating Income	-$5M	$208,698	-2300.2%
Net Income	-$2M	-$208,698	-903.3%